Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Apogee Therapeutics Chief Executive Officer Michael Thomas Henderson sold 20,000 shares of common stock on April 8, 2026, for roughly $1.65 million under a previously adopted Rule 10b5-1 plan. The sales were executed in three transactions at prices between $82.48 and $85.00, as the stock trades close to its 52-week high after a 171% gain over the p…
Spire Global Inc.'s Chief Technology Officer, Johann Gabriel Oehme, reported a sale of 12,757 Class A shares on February 20, 2026, for $108,817. The company has seen its stock climb sharply since that sale and is pursuing a roughly $70 million private placement while expanding satellite-based data products and participating in a geomagnetic measure…
Framework Ventures IV L.P. purchased 54,384 shares of Better Home & Finance Holding Co at $32.96 per share on April 10, 2026, a transaction valued at $1,792,496. The firm now directly holds 1,006,696 shares. The purchase coincides with company disclosures of a robust preliminary Q1 2026 funded loan volume of $1.64 billion, a priced follow-on offeri…
Fermi Inc. Chief Financial Officer Miles E. Everson sold 830,209 shares of common stock on April 8 and April 9, 2026, generating roughly $3.9 million in proceeds. The trades occurred as Fermi shares trade near a 52-week low after an 85% year-over-year decline. Recent quarterly results from Fermi America LLC showed a substantial net loss and elevate…
Charles Lynn Hamilton, Chief Site Development Officer at Fermi Inc (NASDAQ: FRMI), sold 774,090 shares of common stock on April 8 and 9, 2026, for proceeds totaling $3,669,395. The transactions occurred as Fermi's shares traded near a 52-week low and followed the disclosure of fourth-quarter 2025 results showing a sizable net loss and elevated non-…
Fermi Inc. Chief Operating Officer Jacobo Ortiz Blanes sold 830,908 common shares on April 8 and April 9, 2026, for roughly $3.9 million, according to an SEC Form 4. The transactions leave Ortiz Blanes with 5,469,092 directly held shares and a potential beneficial interest in 7,875,000 shares held by an entity he manages. The insider moves come as …
Peter Platzer, Executive Chairman of Spire Global, sold $1,884,577 in Class A common shares through a sequence of transactions recorded between May 20, 2024, and January 21, 2026, according to a Form 4 filing. The trades, executed under transaction code "S," were carried out to satisfy tax obligations tied to restricted stock unit settlements. The …
Spire Global CEO Theresa Condor disposed of 105,667 Class A shares between May 20, 2024 and January 21, 2026 under pre-scheduled sale-to-cover instructions, generating $1,126,487 in gross proceeds. The sales coincided with a sharp run-up in SPIR shares, while the company is pursuing a roughly $70 million private placement and rolling out new data p…
Kevin J. McCallion, senior vice president of Products and Production at 908 Devices Inc. (MASS), exercised options to purchase 24,000 shares and sold those same shares on April 8 and 9, 2026, for roughly $169,091. The transactions occurred as the company reported better-than-expected fourth-quarter 2025 results and received a reaffirmed Buy rating …
Photronics Inc. Chief Executive George Macricostas reported the sale of 120,194 shares on April 8, 2026, in a Form 4 filing, generating $5,203,717. The transactions occurred in three tranches at prices between $42.90 and $43.28. The company recently reported fiscal Q1 2026 results that beat analyst estimates and announced a new mask writer to be in…
Velaga S. Ram, president of Broadcom’s Infrastructure Software Group, reported the sale of 30,215 Broadcom shares across two transactions on April 8 and April 9, 2026, totaling $10,638,012. The disclosures arrive amid several company announcements including a new machine learning fraud-detection product and expanded TPU partnerships with Google and…
Adaptive Biotechnologies NASDAQ:ADPT Chief People Officer Francis Lo sold 22,564 shares on April 8, 2026, under a Rule 10b5-1 plan for roughly $340,039, and exercised options to acquire 2,344 shares the same day. The company’s shares have declined since the sale and InvestingPro flags the stock as appearing overvalued versus its Fair Value estimate…
Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 10,000 shares of common stock on April 8, 2026, for total proceeds of $148,500. The disposals, executed in multiple tranches under a Rule 10b5-1 trading plan adopted in August 2025, occurred at prices between $14.65 and $15.06. After the transactions Robins holds 1,512,058 shar…
Whitehawk Therapeutics Chief Executive Officer David James Lennon sold 14,500 shares of common stock on April 9, 2026, for $3.38 per share, netting $49,010. The sale, disclosed on a Form 4 filing, was executed to meet tax withholding obligations tied to vesting restricted stock units. Separately, the company presented research showing elevated and …
Director Christopher D. Brown sold a combined $282,277 of 908 Devices Inc. (MASS) stock across three trades between April 8 and April 10, 2026. The disposals were made under a Rule 10b5-1 trading plan adopted in November 2025. The company recently reported fourth-quarter 2025 results that beat expectations on both EPS and revenue, and an analyst at…
Broadcom director Justine Page sold 2,018 shares on April 8, 2026, for $353.00 per share, generating proceeds of roughly $712,354. The stock has since risen to $371.57, representing a 117% gain over the last year. Page continues to hold 18,164 shares, including 1,602 restricted stock units. Separately, Broadcom announced a machine learning-driven f…
Snizhana P. Quan, Principal Financial Officer of Lightwave Logic, Inc. (NASDAQ:LWLG), sold 20,000 shares on April 10, 2026, for $207,200 and on the same day exercised options to acquire 20,000 shares at $4.87. The transactions occurred as the stock traded near its 52-week high following strong share gains after the company reported a year-over-year…
David M. Carter, President of Kratos Defense & Security Solutions' DRSS division, sold 4,000 shares on April 8, 2026, for roughly $296,624 across five trades. The company has recently won sizable government contracts, received an analyst upgrade, and added a new director to its board of directors, signaling continued activity across its defense and…
Charlie B Kawwas, president of SSG at Broadcom Inc. (NASDAQ: AVGO), sold 10,000 shares of Broadcom common stock on April 8, 2026, for $3.45 million. Broadcom also unveiled a machine learning-driven fraud detection product for 3-D Secure authentication and announced extended TPU-related agreements with Google and Anthropic through 2031. Analysts iss…
RA Capital Management, a roughly 10% owner and director in Vor Biopharma Inc (NASDAQ: VOR), sold 619,333 shares between April 8 and April 10, 2026, for about $10.2 million. The transactions coincided with a recent week-long 14% decline in VOR shares and follow significant corporate developments at Vor Biopharma including a phase 3 dosing milestone …
Immunovant Chief Legal Officer Christopher Van Tuyl sold 5,165 shares of common stock on April 8, 2026, at a weighted average price of $24.83, generating $128,246 to satisfy tax-withholding obligations tied to vested restricted stock units. The transaction occurred as the stock has climbed sharply over the past year, and follows the company’s annou…
Charles Collier, President of Roku Media, sold 205,821 shares of Roku Class A Common Stock on April 8 at $105 per share for $21.6 million while exercising the same number of employee stock options at varied strike prices totaling $10.7 million, according to a Form 4 filing. The transactions come as Roku shares have risen 73% in the past year and fa…
U.S. Gold Corp. director Luke Anthony Norman reported an indirect purchase of 10,000 common shares on April 8, 2026, at a weighted average price of $14.63, bringing his direct holdings to 278,759 shares. The transaction occurred as the stock traded near that level and follows company updates on the CK Gold Project feasibility economics and a prospe…
Williams-Sonoma Inc.'s Executive Vice President and Chief Financial Officer, Jeffrey Howie, sold 1,419 shares of company stock on April 8, 2026 under a Rule 10b5-1 trading plan, generating $267,410 in proceeds. The transactions, disclosed on a Form 4 filing with the SEC, occurred across a range of prices. The company recently reported fiscal fourth…
Karalyn Yearout, Executive Vice President and Chief Talent Officer at Williams-Sonoma Inc (NYSE: WSM), disposed of 2,267 company shares on April 8, 2026, realizing roughly $436,366. The sales were executed in two blocks under a Rule 10b5-1 trading plan adopted on October 15, 2025. After the transactions Yearout holds 23,351 shares. Williams-Sonoma …
